AbbVie to acquire Botox maker Allergan for $63bn

Boutique PJT Partners lands role on giant $63bn pharma deal

Allergan, known as the maker of Botox, the wrinkle treatment, will give AbbVie access to the cosmetics and beauty market just as its patent ...

AbbVie Pounces On Chance To Buy Revenues In $63bn Mega-Deal ...

AbbVie will gain the $3.58bn Botox business, a women's health franchise and gastrointestinal products in an opportunistic acquisition intended to reduce the ...

US regulator clears AbbVie's $63bn deal for Allergan - Financial Times

A US competition regulator has given the go-ahead for US drugmaker AbbVie to buy Allergan, which makes Botox, in a $63bn deal.

Allergan: AbbVie's expensive facelift | MoneyWeek

Pharma giant AbbVie is buying Botox maker Allergan for $63bn. That's a huge sum given the target's uncertain prospects. Matthew Partridge reports.

Allergan - Healthcare - Economist Intelligence Unit

Beyond Botox. AbbVie is hoping its US$63bn acquisition of Allergan will help it survive the decline of Humira. June 25th 2019 ...

Allergan - Wikipedia

In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. ... "Botox maker Allergan bought by US ...

Botox maker Allergan in $63bn swoop by rival AbbVie - The Telegraph

Botox maker Allergan is being bought by rival AbbVie for about $63bn (£49bn) in the latest blockbuster deal in the pharmaceutical sector.

Abbvie injects $63bn into takeover of Botox-maker Allergan - CityAM

US drugmaker Abbvie is set to buy the maker of Botox, Allergan, in a $63bn bid to reduce its reliance on the world's best-selling drug Humira.

AbbVie to buy Allergan in $63bn deal | Irish Independent

Drug company AbbVie is to buy Botox-maker Allergan for around $63bn (€55bn), grabbing control of by far the biggest name in medical ...

Abbvie hopes for $63bn facelift with Botox deal - The Times

... buy the Ireland-based maker of Botox in one of the ... The acquisition of Allergan gives Abbvie access to the $8 billion Botox market.

Caroline Rogers on LinkedIn: AbbVie to acquire Botox maker ...

AbbVie to acquire Botox maker Allergan for $63bn.

Financial Times on X: "US drugmaker AbbVie has agreed to buy ...

US drugmaker AbbVie has agreed to buy Allergan, the maker of Botox, in a deal worth about $63bn that marks the latest blockbuster transaction in the ...

US biopharmacy firm AbbVie to buy Allergan for $63bn - PressReader

Paris, France – US biopharmacy company AbbVie said on Tuesday it had agreed to buy rival drugmaker Allergan, the maker of Botox, ...

AbbVie to acquire Allergan for $63bn - Mubasher Info

Mubasher: Biotech company AbbVie on Tuesday said it would buy Allergan, the Irish-based maker of Botox, for $63 billion.

Botox-maker Allergan 'committed to Ireland' despite agreeing €55bn ...

... AbbVie in a $63bn (€55.3bn) deal ... The expected cost savings from the AbbVie-Allergan deal will buy both companies more time but not ...

AbbVie set to buy Botox-maker Allergan for $63 bn - Qatar Tribune

Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical ...

US AbbVie to acquire Irish Botox-maker Allergan for $63 bn

Chicago: The specialty drug company AbbVie will spend $63 billion to acquire Allergan, the maker of Botox and other cosmetic treatments.

Monika Naturalna on LinkedIn: AbbVie to acquire Botox maker ...

Monika Naturalna's Post · AbbVie to acquire Botox maker Allergan for $63bn · More Relevant Posts · Artificial Intelligence Is Transforming Biotechnology, ...

US biopharma AbbVie to buy Botox maker Allergan for $63 bn

US biopharmaceutical company AbbVie said Tuesday it would buy Botox-maker Allergan for about $63 billion, moving to diversify its product line as the ...

AbbVie acquires Allergan - Financier Worldwide

In a deal that is likely to be one of the largest healthcare mergers of the year, US drug manufacturer AbbVie has agreed to buy Irish Botox ...